Thomas Connolly - Net Worth and Insider Trading

Thomas Connolly Net Worth

The estimated net worth of Thomas Connolly is at least $16 Million dollars as of 2024-09-21. Thomas Connolly is the SVP, Human Resources of Vertex Pharmaceuticals Inc and owns about 34,525 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $16 Million. Details can be seen in Thomas Connolly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Connolly has not made any transactions after 2014-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Thomas Connolly

To

Thomas Connolly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Connolly owns 1 companies in total, including Vertex Pharmaceuticals Inc (VRTX) .

Click here to see the complete history of Thomas Connolly’s form 4 insider trades.

Insider Ownership Summary of Thomas Connolly

Ticker Comapny Transaction Date Type of Owner
VRTX Vertex Pharmaceuticals Inc 2014-12-12 SVP & Human Resources

Thomas Connolly Latest Holdings Summary

Thomas Connolly currently owns a total of 1 stock. Thomas Connolly owns 34,525 shares of Vertex Pharmaceuticals Inc (VRTX) as of December 12, 2014, with a value of $16 Million.

Latest Holdings of Thomas Connolly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRTX Vertex Pharmaceuticals Inc 2014-12-12 34,525 464.92 16,051,363

Holding Weightings of Thomas Connolly


Thomas Connolly Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Connolly has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 520 shares on December 12, 2014, which brought Thomas Connolly around $62,431.

Insider Trading History of Thomas Connolly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Connolly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Connolly Ownership Network

Ownership Network List of Thomas Connolly

No Data

Ownership Network Relation of Thomas Connolly

Insider Network Chart

Thomas Connolly Owned Company Details

What does Vertex Pharmaceuticals Inc do?

Who are the key executives at Vertex Pharmaceuticals Inc?

Thomas Connolly is the SVP & Human Resources of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and CMO Carmen Bozic , director & CEO & President Reshma Kewalramani , and EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii .

Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary

Over the past 18 months, Thomas Connolly made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 80,549 shares made by Reshma Kewalramani , and a net sale of 62,114 shares made by Jeffrey M Leiden .

In summary, during the past 3 months, insiders sold 50,541 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 50,541 shares. During the past 18 months, 394,733 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 394,733 shares.

Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vertex Pharmaceuticals Inc Insider Transactions

No Available Data

Thomas Connolly Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Connolly. You might contact Thomas Connolly via mailing address: 717 Fifth Avenue, 9th Floor, New York Ny 10022.

Discussions on Thomas Connolly

No discussions yet.